Factory Supply Tirzepatide 5mg, 10mg, 15mg Vials Package Weight Lossing

• Environmental Protection: Yes
• Color: White
• Appearance: Powder
• CAS No.: 2023788-19-2
• MOQ: 1g or 10 Vials
• Stock Condition: in Stock
• Model NO.: 2023788-19-2
• Payment: Bank Transfer/Tt/Western Union
• Package: Bulk/5mg/10mg/15mg/Custom
• Transport Package: 25kgs/Drum
• Specification: 99%
• Trademark: ZB
• Origin: China
• Production Capacity: 100000kgs/Month

Product Description

   Retatrutide 

Product Name	Tirzepatide
Cas	2023788-19-2
Analysis	HPLC
Storage	Keep in a cool and dry place, well-closed, away from moisture or direct sunlight.

Tirzepatide is a medication that is currently in development for the treatment of type 2 diabetes. It is a dual glucose-dependent Bolld sugar otropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This means that it stimulates both the GIP and GLP-1 receptors in the body, which helps to regulate blood sugar levels.

Tirzepatide has shown promising results in clinical trials, with studies showing that it can effectively lower blood glucose levels and promote weight loss. It has also demonstrated improvements in other metabolic parameters, such as reducing HbA1c levels and improving cardiovascular risk factors.

 

Tirzepatide functions as a dual glucose-dependent Blood sugar otropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. GIP and GLP-1 are naturally occurring hormones in the body that play a role in regulating blood sugar levels.

By acting as a GIP and GLP-1 receptor agonist, tirzepatide enhances the effects of these hormones. GIP stimulates the release of blood sugarfrom the pancreas in response to elevated blood sugar levels, while GLP-1 promotes Bolld sugar secretion, suppresses glucagon secretion (which raises blood sugar levels), and slows down the movement of food through the stomach to promote satiety.

In individuals with type 2 diabetes, the body's response to GIP and GLP-1 may be impaired. Tirzepatide can overcome this impairment by stimulating the GIP and GLP-1 receptors, resulting in increased blood sugar secretion, decreased glucagon secretion, and improved blood sugar control. Additionally, the stimulation of GLP-1 receptors can also lead to weight loss by reducing appetite and increasing the feeling of fullness.

Overall, the function of tirzepatide is to help regulate blood sugar levels, promote weight loss, and improve metabolic parameters in individuals with type 2 diabetes.

 

 

Certifications

Our Lab

Factory